Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-20
1994-04-05
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 514275, 540362, 544250, 544252, 544255, A61K 31505, C07D491048
Patent
active
053005090
ABSTRACT:
Compounds of formula I, and pharmaceutically acceptable salts thereof, ##STR1## in which R1 is hydrogen (1-6C)alkyl or (1-4C)alkanoyl;
REFERENCES:
patent: 2807616 (1957-09-01), Falco et al.
Sato and Saito, "Studies on Pyrazines. 17. [1]. An Efficient Synthesis of Pteridine-6-carboxylic Acids," J. Heterocyclic Chem., vol. 25, (1988), pp. 1737-1740.
"Furterene," The Merck Index, 11th Ed., published by Merck and Co., Rahway, N.J., (1989), p. 675, entry 4224.
Temple et al., "Synthesis of Potential Antimalarial Agents. VII. Azaquinolines. I. The Preparation of Some Pteridines and Pyrido [3,4-b] pyrazines (1),", J. Heterocyclic Chem., vol. 7, (Oct. 1970), pp. 1195-1202.
H S. El Khadem and R. Sindric, "Synthesis of 8-(hydroxyalkyl)adenines*", Carbohydrate Research, (May 1974), vol. 34, No. 1, pp. 203-207.
Block Michael H.
Hargreaves Rodney B.
Harrison Alison
Gupta Y. N.
Imperial Chemical Industries plc
Shah Mukund J.
LandOfFree
2-furyl-oxazolo[5,4-d]-pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-furyl-oxazolo[5,4-d]-pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-furyl-oxazolo[5,4-d]-pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511214